In vivo imaging of herpes simplex virus type 1 thymidine kinase gene expression: Early kinetics of radiolabelled FIAU

European Journal of Nuclear Medicine

Volumn 27, Issue 3, 2000, Pages 283-291

  Haubner, Roland ^a,b   Avril, Norbert ^a   Hantzopoulos, Petros A ^a   Gansbacher, Bernd ^a   Schwaiger, Markus ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Gene therapy; HSV1 tk; Imaging; Radiolabelled FIAU

Indexed keywords

DNA; FIALURIDINE; IODINE 123; IODINE 125; THYMIDINE KINASE; TRACER;

ARTICLE; DRUG DISTRIBUTION; DRUG ELIMINATION; ENZYME ACTIVITY; GENE EXPRESSION; HERPES SIMPLEX VIRUS 1; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMAGING; ISOTOPE LABELING; KINETICS; MOUSE; NONHUMAN; REPORTER GENE; SCINTILLATION CAMERA;

EID: 0034073577     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590050035     Document Type: Article

References (30)

1. Verma IM, Somia N. Gene therapy, promises, problems and prospects. Nature 1997; 389: 239-242.
2. Anderson WF. Human gene therapy. Nature 1998; 392: 25-30.
3. Brenner MK. Human somatic gene therapy: progress and problems. J Intern Med 1995; 237: 229-239.
4. Freeman SM, Whartenby KA, Freeman JL, Abbound CN, Marrogi AJ. In situ use of suicide genes for cancer therapy. Semin Oncol 1996; 23: 31-45.
5. Larson SM, Tjuvajev J, Blasberg R. Triumph over mischance: a role for nuclear medicine in gene therapy. J Nucl Med 1997; 38: 1230-1233.
6. Tjuvajev JG, Finn R, Watanabe K, Joshi R, Oku T, Kennedy J, Beattie B, Koutcher J, Larson S, Blasberg RG. Noninvasive imaging of herpes virus thymidine kinase gene transfer and expression: a potential method for monitoring clinical gene therapy. Cancer Res 1996; 56: 4087-4095.
7. MacLaren DC, Gambhir SS, Satyamurthy N, Barrio, JR, Sharfstein S, Toyokuni T, Wu L, Berk AJ, Cherry SR, Phelps ME, Herschman H. Repetitive, non-invasive imaging of the dopamine D2 receptor as a reporter gene in living animals. Gene Ther 1999; 6: 785-791.
8. 2 in ovarian carcinoma induced to express the gastrin releasing peptide receptor by adenoviral vector-mediated gene transfer. J Nucl Med 1997; 38: 1221-1229.
9. 11C]-FMAU): a potential nucleoside analog for in vivo study of cellular proliferation with PET. Nucl Med Biol 1995; 22: 783.
10. 18F]FHBG): a new potential imaging agent for viral infection and gene therapy using PET. Nucl Med Biol 1998; 25: 175-180.
11. 18F]-FHPG): a potential imaging agent of viral infection and gene therapy using PET. Nucl Med Biol 1996; 23: 787-792.
12. Haberkorn U, Altmann A, Morr I, Knopf KW, Germann C, Haeckel R, Oberdorfer F, van Kaick G. Monitoring gene therapy with herpes simplex virus thymidine kinase in hepatoma cells: uptake of specific substrates. J Nucl Med 1997; 38: 287-294.
13. Germann C, Shields AF, Grierson JR, Morr I, Haberkorn U. 5-Fluoro-1-(2'-deoxy-2'-fluoro-β-D-ribofuranosyl) uracil trapping in Morris hepatoma cells expressing the herpes simplex virus thymidine kinase gene. J Nucl Med 1998; 39: 1418-1423.
14. Gambhir SS, Barrio JR, Wu L, Iyer M, Namavari M, Satyamurthy N, Bauer E, Parrish C, MacLaren DC, Borghei AR, Green LA, Sharfstein S, Berk AJ, Cherry SR, Phelps ME, Herschman HR. Imaging of adenoviral-directed herpes simplex virus type 1 thymidine kinase reporter gene expression in mice with radiolabelled ganciclovir. J Nucl Med 1998; 39: 2003-2011.
15. 211At]astato-1-[2-deoxy-2-fluoro-β-D-arabinofuranosyl) uracil by a halodestannylation reaction. Nucl Med Biol 1998; 25: 487-496.
16. Saito Y, Price RW, Rottenberg DA, Fox JJ, Su TL, Watanabe KA, Philips FS. Quantitative autoradiographic mapping of herpes simples virus encephalitis with a radiolabelled antiviral drug. Science 1982; 217: 1151-1153.
17. Tjuvajev JG, Stockhammer G, Desai R, Uehara H, Watanabe K, Gansbacher B, Blasberg RG. Imaging the expression of transfected genes in vivo. Cancer Res 1995; 55: 6126-6132.
18. Tjuvajev JG, Avril N, Oku T, Sasajima T, Miyagawa T, Joshi R, Safer M, Beattie B, DiResta G, Daghighian F, Augensen F, Koutcher J, Zweit J, Humm J, Larson SM, Finn R, Blasberg R. Imaging herpes virus thymidine kinase gene transfer and expression by positron emission tomography. Cancer Res 1998; 58: 4333-4341.
19. 14C]-1-(2-deoxy-2'-fluoro-β-D-arabinofuranosyl)-5- iodocytosine in immuno-suppressed patients with herpesvirus infections. Antimicrob Agents Chemother 1985; 27: 733-738.
20. Shields AF, Grierson JR, Kozawa SM, Zheng M. Development of labelled thymidine analogs for imaging tumour proliferation. Nucl Med Biol 1996; 23: 17-22.
21. Chou TC, Feinberg A, Grant AJ, Vidal P, Reichman U, Watanabe KA, Fox JJ, Philips FS. Pharmacological disposition and metabolic fate of 2'-fluoro-5-iodo-1-β-D-arabinofuranosylcytosine in mice and rats. Cancer Res 1981; 41: 3336-3342.
22. Gambhir SS, Barrio JR, Phelps ME, Iyer M, Namavari M, Satymurthy N, Wu L, Green LA, Bauer E, MacLaren DC, Nguyen K, Berk AJ, Cherry SR, Herschman HR. Imaging adenoviral-directed reporter gene expression in living animals with positron emission tomography. Proc Natl Acad Sci USA 1999; 96: 2333-2338.
23. 18F]FHPG) in a two-sided tumour-bearing rat model. J Labelled Compd Radiopharm 1999; 42: S7-S9.
24. 18F]fluoro-3-hydroxy-2-propoxy)methyl}guanine: a radiopharmaceutical for gene therapy. J Labelled Compd Radiopharm 1999; 42: S10-S12.
25. 18F]-FHPG) in vitro and in vivo as a probe for PET imaging of gene incorporation and expression in tumours. Nucl Med Biol 1999; 26: 371-376.
26. Alauddin MM, Shiahinian A, Gordon EM, Conti PS. Evaluation of F-18 9-(4-fluoro-3-hydroxymethylbutyl)guanine ([F-18]FHBG) as a PET imaging agent for gene exprsssion in tumour bearing nude mice. J Nucl Med 1999; 40: 26P.
27. Goethals P, Lameire N, van Eijkeren M, Kesteloot D, Thierens H, Dams R. [Methyl-carbon-11]thymidine for in vivo measurement of cell proliferation. J Nucl Med 1996; 37: 1048-1052.
28. Shields AF, Lim K, Grierson J, Link J, Krohn KA. Utilization of labelled thymidine in DNA synthesis: studies for PET. J Nucl Med 1990; 31: 337-342.
29. 11C]thymidine. J Labelled Compd Radiopharm 1999; 42: S678-S680.
30. 131I]FIAU. J Nucl Med 1999; 40: 26P.